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Summary
Three international panels have been established over the past 11 years to provide veterinarians with guidelines on the use of feline vaccines. These are the American Association of Feline Practitioners (AAFP) Feline Vaccine Advisory Panel, the World Small Animal Association Vaccine Guidelines Group (WSAVA VGG) and the European Advisory Board on Cat Diseases (ABCD). The major recommendations of these three panels are summarised to show areas of agreement and areas of discrepancy. While the recommendations of the three groups are not fully aligned, all agree that core vaccines (those that every cat should receive) include panleucopenia virus (FPV), calicivirus (FCV) and herpesvirus (FHV-1) (with the addition of rabies virus where it is endemic or mandated by law). All the panels also recommend booster vaccination for the three core vaccines at intervals of more than one year in many situations (up to every three years for FCV and FHV-1 after the fi rst booster, and at intervals no more frequently than every three years for FPV after the fi rst booster), in view of the studies evaluating the duration of immunity for these vaccines. Precise recommendations vary though, and further studies are needed to provide additional information to clarify areas of discrepancy and further refi ne recommendations for the future. Ultimately the aim should be to vaccinate cats less frequently (based on a knowledge of the true duration of immunity conferred by vaccination), but to vaccinate more cats (and ideally every cat). 
Feline vaccination protocols: is a consensus emerging?
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Centre for Small Animal Studies, Animal Health Trust, Lanwades Park, Kentford, Suffolk, UK Prevention of disease is the ultimate goal of veterinarians, and there is no doubt that the widespread use of vaccines has contributed enormously to achieving that ambition. The current prevalence of vaccination in cat populations is not high enough to achieve a good level of herd immunity and elimination of infectious agents (Horzinek and Thiry, 2009 ) and so containment and control is a more realistic goal, along with protection of the individual animal. Nevertheless, as has been stated by the World Small Animal Association (WSAVA) Vaccine Guidelines Group second strand of evidence has come from studies of duration of immunity (DOI) for vaccines. In the past, there has been a tendency for minimum DOI studies to be done for licensing purposes and/or for arbitrary annual vaccination boosters to be recommended . Some vaccine manufacturers are now undertaking the (more expensive) studies to determine more than just minimal DOI for vaccines, and other studies have emerged that have provided good evidence on prolonged DOI for a number of vaccines (see, for example, Scott and Geissinger, 1997; Geissinger, 1999, Coyne et al., 2001; Lappin et al., 2002; Mouzin et al., 2004) . Thus the combined knowledge of occasional serious adverse reactions to vaccination, and for some vaccines growing evidence of a DOI well in excess of a year, has led to a serious re-evaluation of vaccination recommendations. There are now three international panels that have been established to provide guidelines on feline vaccination protocols -the American Association of Feline Practitioners Feline Vaccine Advisory Panel which fi rst reported (VGG), our aim should be to vaccinate every animal and each individual animal less frequently (Day et al., 2007) . In recent years, two particular lines of evidence have caused a re-evaluation of traditional vaccine recommendations. The fi rst is the recognition that vaccination is not innocuous and that serious side effects sometimes occur. Various side effects are associated with vaccination with studies suggesting a prevalence of between 3 % and 25 % depending on the vaccine and how the data is collected (Rosenthal and Dworkis, 1990a; Rosenthal and Dworkis, 1990b; Clark et al., 1991; Pollock and Haffer, 1991; Starr, 1993; Gobar and Kass, 2002) . Most of these adverse reactions are mild and transient, but occasionally severe and life-threatening events can occur such as severe hypersensitivity reactions or the more recently recognised injection-site sarcoma phenomenon in cats (Davis-Wurzler, 2006; Horzinek and Thiry, 2009 ). The recognition of such devastating side effects, albeit seen rarely, challenges the notion that vaccination is a safe procedure and that vaccine intervals are not an important consideration. The
AAFP Guidelines
WSAVA Guidelines ABCD Guidelines Nature of vaccine Core Core Core
Primary vaccination of kittens
Begin from as early as 6 weeks, then every 3 -4 weeks until 16 weeks of age
Begin at 8 -9 weeks with a second 3 -4 weeks later and a fi nal vaccine at 16 weeks of age
Begin at 8 -9 weeks with a second 3 -4 weeks (minimum 12 weeks). Consider a fi nal dose at 16 -20 weeks of age Consider starting earlier than 8 weeks and repeating
Primary vaccination in cats ≥ 16w
Two doses 3 -4 weeks apart Two doses 3 -4 weeks apart
Vaccination of adult cats of unknown status
A single dose of MLV in adults of unknown status followed by a booster after 1 year A single dose of MLV in adults of unknown status followed by a booster after 1 year 
AAFP Guidelines WSAVA Guidelines ABCD Guidelines
Nature of vaccine Non-core Non-core Non-core
Primary vaccination of kittens
Begin as early as 8 weeks then second 3 -4 weeks later
Begin at 8 -9 weeks with a second dose at 12 weeks
Primary vaccination in cats ≥ 16w
Two doses 3 -4 weeks apart Two doses 3 -4 weeks apart Two doses 3 -4 weeks apart Table 5 : Guideline recommendations for rabies vaccination.
AAFP Guidelines WSAVA Guidelines ABCD Guidelines
Nature of vaccine Not generally recommended Not recommended
Primary vaccination of kittens
Two doses 2 -4 weeks apart from 8 weeks Two doses 2 -4 weeks apart from 8 weeks
Booster vaccinations Annual (recommended by manufacturer) Annual (recommended by manufacturer)
Additional information
Insuffi cient data to support vaccination Insuffi cient data to support vaccination 
AAFP Guidelines WSAVA Guidelines ABCD Guidelines
Primary vaccination of kittens
Two doses 3 -4 weeks apart from 9 weeks of age Two doses 3 -4 weeks apart from 9 weeks of age Two doses 3 -4 weeks apart starting at 8 -10 weeks
Primary vaccination in cats ≥ 16w
Two doses 3 -4 weeks apart Two doses 3 -4 weeks apart Two doses 3 -4 weeks apart (Horzinek et al., 2009 ). The major recommendations from these three bodies are summarised in Tables 1 -9 . While there are differences between the recommendations of the three groups (as can be seen), there is a clear consensus among them too on many aspects. All the groups recommend that vaccines should not be given needlessly; that an annual health check is advisable irrespective of whether vaccines are given; that owners should be involved with discussions, and the risks and benefi ts of vaccination explored so that informed consent is given; that adverse reactions to vaccinations should be properly reported to vaccine manufacturers and regulatory authorities; and that vaccines should be regarded as core (where vaccination of all cats is justifi able) and non-core (where vaccination can only be justifi ed in certain circumstances). All three groups have also recommended booster vaccination schedules that include extended intervals (beyond the traditional 12 months), especially for the core vaccines (where more data is available), but that choices should be made on an individual basis and protocols cannot be formulated that are suitable for all cats in all circumstances. These are important principles and show the way to a more enlightened use of vaccines in the future. Perhaps of note is the fact that in the USA, since 1998 when the AAFP fi rst introduced recommendations suggesting booster vaccination for core vaccines may given less frequently (e.g. every three years), despite apparent widespread uptake of this recommendation there have been no reports or suggestions of outbreaks of disease that would otherwise have been prevented. More information is still needed to reconcile some of the discrepancies between the recommendations of these three groups and to provide a greater evidence base for ongoing refi nement and changes to these recommendations, but there is now emerging an international consensus whereby veterinarians can clearly identify with the WSAVA stated aim of vaccinating every animal but each individual less frequently.
Booster vaccinations
AAFP Guidelines WSAVA Guidelines ABCD Guidelines
Nature of vaccine Non-core Non-core Non-core 
